TARS - Tarsus Pharmaceuticals EPS beats by $0.72 May, 11 2021 04:46 PM Tarsus Pharmaceuticals Inc. Tarsus Pharmaceuticals (TARS): Q1 GAAP EPS of $0.47 beats by $0.72.Revenue of $33.43MCash and cash equivalents of $156.2MPress Release For further details see: Tarsus Pharmaceuticals EPS beats by $0.72